Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2021 08:00 ET | Source: MiNK Therapeutics

MiNK Therapeutics Presents New Preclinical and Clinical Data on iNKT Cell Therapy Programs at SITC 2021

NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf,...
October 19, 2021 16:25 ET | Source: MiNK Therapeutics

MiNK Therapeutics Announces Closing of Initial Public Offering

NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf,...
October 14, 2021 20:29 ET | Source: MiNK Therapeutics

MiNK Therapeutics, Inc. Announces Pricing of Initial Public Offering

NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (“MiNK”), a clinical stage biotechnology company pioneering the discovery, development, and commercialization of allogeneic,...
October 01, 2021 08:00 ET | Source: MiNK Therapeutics

MiNK Therapeutics to Present Three Abstracts on Novel Allogeneic iNKT Programs at SITC

NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf,...